Wang Xiaoyi resigned as chief executive officer and chief research officer of BrainAurora Medical Technology (HKG:6681), effective June 19, a Friday filing to the Hong Kong bourse said.
Wang cited deteriorating health due to depression linked to the company's listing process as the reason for his departure, according to the filing.
Cai Longjun, currently chief technology officer and chief operating officer, has been appointed to act as CEO and CRO with immediate effect.
He will also assume legal and managerial responsibilities across BrainAurora's subsidiaries previously held by Wang.